⌘K

Login Start Free

Home/Filings/4/0001053369-16-000042

4//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 4

Accession 0001053369-16-000042

$ELTPCIK 0001053369operating

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 7:49 PM ET

Size

14.8 KB

Accession

0001053369-16-000042

Insider Transaction Report

Form 4

Period: 2016-01-29

ELITE PHARMACEUTICALS INC /NV/eltp

DirectorChairman & CEO

Transactions

Sale
Common Stock
2016-01-29$0.35/sh−115,000$40,250→ 9,081,769 total
Sale
Common Stock
2016-02-01$0.34/sh−312,300$106,182→ 8,769,469 total
Sale
Common Stock
2016-02-02$0.33/sh−13,000$4,290→ 8,756,469 total
Sale
Common Stock
2016-02-03$0.33/sh−45,518$15,021→ 8,710,951 total
Sale
Common Stock
2016-02-05$0.33/sh−24,400$8,052→ 8,336,891 total
Sale
Common Stock
2016-02-04$0.32/sh−349,660$111,891→ 8,361,291 total
Award
Common Stock
2016-02-16$0.25/sh+124,646$30,900→ 8,461,537 total
Sale
Common Stock
2016-02-17$0.31/sh−50,000$15,580→ 8,411,537 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating

IncorporatedNJ

Related Parties

1

filerCIK 0001053369

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 7:49 PM ET
Size: 14.8 KB

View on SEC.gov